SONIA LILIANA BETANCOURT CUELLAR to Ipilimumab
This is a "connection" page, showing publications SONIA LILIANA BETANCOURT CUELLAR has written about Ipilimumab.
Connection Strength
0.027
-
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers. Mol Cancer Ther. 2018 03; 17(3):671-676.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.